Amarin Corp Plc (AMRN)

[johngnatt]

I agree. My concern is this may partially handicap Hikma ( if Amarin wins) but noting more. They can get their acts together and other generics have the field open to just make the drug available. The more use the drug gets the generic will be automatically written without any inducement. Unless the FDA orange book make an explicit statement that generic is not AB rated to Vascepa, the US market is gone.

On your end, I am hoping this is the best chance. Getting a hearing for your case is the most important thing.

A question for you.

When a judge makes a scientifically incorrect conclusion and it is presented by the judge in writing, why is it difficult to correct the course? When it can be easily proven that conclusion is fundamentally incorrect and FALSE and forms the primary basis of the final ruling, there have to be better option to bring the error to the courts notice.